Laennec Placenta Inj
Laennec Placenta Inj
Обычная цена
$700.00USD
Обычная цена
Цена со скидкой
$700.00USD
Цена за единицу
/
за
(JBP - Japan)
Packaging
2 ml 50 ampoules
Active ingredient: human placenta hydrolysate 112mg.
Description
This product is a light yellow-brown or yellow-brown clear liquid with a distinctive odor. The pH level ranges from 5.5 to 6.5 and the osmotic pressure ratio (to physiological saline) is approximately one.
Start sales: in Japan after clinical trials of Laennec in 1979, July.
Indications
Common ailments
General fatigue
Stiffness of shoulders
Anemia
Raynaud disease
Male and female sexual sphere
Prostatic hypertrophy
Menopause and Andropause (male menopause)
Dysmenorrhea
Ovarian Dysfunction
Frigidity
Alimentary system
Chronic constipation
Gastroptosis
Gastric ulcer
Dyspepsia
Hepatitis
Liver cirrhosis
Skin
Urticaria (hives)
Eczema
Melasma
Keloid scar
Lupus
- Eliminates insomnia and improves physical fatigue
- Boosts the immune system
- Stimulates the regeneration of liver cells
- Drastically improves skin elasticity
- Boosts the immunodefences
- Improves circulation
Laennec combines ancient traditions and unique modern Japanese technologies.
Modern medicine prefers natural drugs having strong healing effects, lacking side effects and don’t building up a tolerance. As a placental biologic drug, Laennec has a polyfunctional effect on all organs and internal systems. Placental therapy allows to increase the phase of active aging, to live a full life at any age and to look great. That’s not just a way to cure many illnesses, but also a way to prevent them.
Injection administration of Laennec promotes regeneration and renewal of body cells, supports physiological regeneration and corrects life processes.
Laennec’s clinical efficiency and safety is proved by a 55 years long usage in Japanese clinics for treating more than 80 illnesses and by various trials in Russian medical centers: The Burdenko Main Military Clinical Hospital, FSBI Federal State Medical and Research Center of the Russian Federation Presidential Administration, FMBA of Russia State Immunology Research Center. Long clinical use of Laennec has proved his efficient hepatoprotective and immunomodulating properties. Laennec was authorized for use in Russia in 2003 as a hepatoprotector and in 2008 as an immune response-modulating agent; product license #013851/01.
Laennec administration normalizes liver biochemical values, improves liver’s detoxification and metabolic functions and boosts immune system. The drug revitalizes the body, eliminates fatigue, boosts neural activity and increases tolerance to stress, it is also effective as a treatment of dermatological issues and as a component of esthetic programs.
Anti-age therapy and body bioactivation – improvement of the quality of life, body detoxification, boost of tolerance, performance in the workplace and stress resistance, state of health and mood improvement, hormonal panel normalization, correction of biological age.
Cosmetology – rejuvenation at the cellular level, lifting effect, improvement of the skin quality: rhytides effacement, improvement of skin elasticity and humidity.
Dermatology – treatment of atopic dermatitis, psoriasis, acne, recurring herpes and age spots.
Hepatology – liver cells regeneration, treatment of alcohol and toxic hepatitis, acute and chronic viral hepatitis, alimentary hepatic steatosis and hepatic cirrhosis.
Gynecology – chronic endometritis as an infertility reason, unsuccessful EF, habitual miscarriage and postmenopausal syndrome (as a preventive care).
Japanese state placental rehabilitation program Laennec provides an opportunity for fundamental restoration and rejuvenation of a body and a modern high quality treatment of serious diseases.
Recent Studies:
http://www.koreabiomed.com/news/articleView.html?idxno=8238
Dosage and Administration
The normal adult dose is a 2 ml once daily. According to symptoms, the dose can be increased to 2 or 3 times daily.
Expiry date is less than 2 year (about 1 - 1,5 years). One box of 50 vials is for 5-6 months course. Apply one vial every 2 days for 2 months, then repeat in 1 - 1,5 months. -
Packaging
2 ml 50 ampoules
Active ingredient: human placenta hydrolysate 112mg.
Description
This product is a light yellow-brown or yellow-brown clear liquid with a distinctive odor. The pH level ranges from 5.5 to 6.5 and the osmotic pressure ratio (to physiological saline) is approximately one.
Start sales: in Japan after clinical trials of Laennec in 1979, July.
Indications
Common ailments
General fatigue
Stiffness of shoulders
Anemia
Raynaud disease
Male and female sexual sphere
Prostatic hypertrophy
Menopause and Andropause (male menopause)
Dysmenorrhea
Ovarian Dysfunction
Frigidity
Alimentary system
Chronic constipation
Gastroptosis
Gastric ulcer
Dyspepsia
Hepatitis
Liver cirrhosis
Skin
Urticaria (hives)
Eczema
Melasma
Keloid scar
Lupus
- Eliminates insomnia and improves physical fatigue
- Boosts the immune system
- Stimulates the regeneration of liver cells
- Drastically improves skin elasticity
- Boosts the immunodefences
- Improves circulation
Laennec combines ancient traditions and unique modern Japanese technologies.
Modern medicine prefers natural drugs having strong healing effects, lacking side effects and don’t building up a tolerance. As a placental biologic drug, Laennec has a polyfunctional effect on all organs and internal systems. Placental therapy allows to increase the phase of active aging, to live a full life at any age and to look great. That’s not just a way to cure many illnesses, but also a way to prevent them.
Injection administration of Laennec promotes regeneration and renewal of body cells, supports physiological regeneration and corrects life processes.
Laennec’s clinical efficiency and safety is proved by a 55 years long usage in Japanese clinics for treating more than 80 illnesses and by various trials in Russian medical centers: The Burdenko Main Military Clinical Hospital, FSBI Federal State Medical and Research Center of the Russian Federation Presidential Administration, FMBA of Russia State Immunology Research Center. Long clinical use of Laennec has proved his efficient hepatoprotective and immunomodulating properties. Laennec was authorized for use in Russia in 2003 as a hepatoprotector and in 2008 as an immune response-modulating agent; product license #013851/01.
Laennec administration normalizes liver biochemical values, improves liver’s detoxification and metabolic functions and boosts immune system. The drug revitalizes the body, eliminates fatigue, boosts neural activity and increases tolerance to stress, it is also effective as a treatment of dermatological issues and as a component of esthetic programs.
Anti-age therapy and body bioactivation – improvement of the quality of life, body detoxification, boost of tolerance, performance in the workplace and stress resistance, state of health and mood improvement, hormonal panel normalization, correction of biological age.
Cosmetology – rejuvenation at the cellular level, lifting effect, improvement of the skin quality: rhytides effacement, improvement of skin elasticity and humidity.
Dermatology – treatment of atopic dermatitis, psoriasis, acne, recurring herpes and age spots.
Hepatology – liver cells regeneration, treatment of alcohol and toxic hepatitis, acute and chronic viral hepatitis, alimentary hepatic steatosis and hepatic cirrhosis.
Gynecology – chronic endometritis as an infertility reason, unsuccessful EF, habitual miscarriage and postmenopausal syndrome (as a preventive care).
Japanese state placental rehabilitation program Laennec provides an opportunity for fundamental restoration and rejuvenation of a body and a modern high quality treatment of serious diseases.
Recent Studies:
http://www.koreabiomed.com/news/articleView.html?idxno=8238
Dosage and Administration
The normal adult dose is a 2 ml once daily. According to symptoms, the dose can be increased to 2 or 3 times daily.
Expiry date is less than 2 year (about 1 - 1,5 years). One box of 50 vials is for 5-6 months course. Apply one vial every 2 days for 2 months, then repeat in 1 - 1,5 months. -